Geneos Wealth Management’s iShares Morningstar US Equity ETF ILCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Buy
2,435
+6
+0.2% +$564 0.01% 935
2025
Q4
$229K Buy
2,429
+7
+0.3% +$656 0.01% 888
2025
Q3
$224K Buy
2,422
+7
+0.3% +$623 0.01% 867
2025
Q2
$207K Sell
2,415
-4,801
-67% -$380K 0.01% 978
2025
Q1
$558K Buy
7,216
+4,015
+125% +$327K 0.01% 852
2024
Q4
$260K Buy
3,201
+76
+2% +$6.2K 0.01% 753
2024
Q3
$248K Buy
3,125
+8
+0.3% +$611 0.01% 717
2024
Q2
$234K Buy
3,117
+6
+0.2% +$434 0.01% 669
2024
Q1
$225K Buy
3,111
+7
+0.2% +$482 0.01% 674
2023
Q4
$204K Buy
3,104
+21
+0.7% +$1.29K 0.01% 669
2023
Q3
$182K Sell
3,083
-1
-0% -$61 0.01% 711
2023
Q2
$188K Buy
3,084
+2,284
+286% +$132K 0.01% 697
2023
Q1
$45.1K Sell
800
-2,268
-74% -$125K ﹤0.01% 1111
2022
Q4
$162K Buy
3,068
+11
+0.4% +$582 0.01% 695
2022
Q3
$151K Sell
3,057
-189
-6% -$10.4K 0.01% 682
2022
Q2
$170K Buy
3,246
+7
+0.2% +$396 0.01% 807
2022
Q1
$203K Sell
3,239
-945
-23% -$58.5K 0.01% 798
2021
Q4
$277K Buy
4,184
+9
+0.2% +$582 0.01% 753
2021
Q3
$256K Buy
4,175
+7
+0.2% +$437 0.01% 762
2021
Q2
$256K Sell
4,168
-12,480
-75% -$736K 0.01% 749
2021
Q1
$245K Buy
16,648
+12,148
+270% +$668K 0.01% 885
2020
Q4
$252K Buy
4,500
+2,208
+96% +$113K 0.01% 749
2020
Q3
$109K Hold
2,292
0.01% 910
2020
Q2
$97K Hold
2,292
0.01% 927
2020
Q1
$82K Hold
2,292
0.01% 910
2019
Q4
$105K Hold
2,292
0.01% 931
2019
Q3
$95K Sell
2,292
-464
-17% -$19.3K 0.01% 913
2019
Q2
$113K Buy
2,756
+4
+0.1% +$163 0.01% 859
2019
Q1
$110K Hold
2,752
0.01% 830
2018
Q4
$97K Hold
2,752
0.01% 841
2018
Q3
$115K Hold
2,752
0.01% 838
2018
Q2
$105K Hold
2,752
0.01% 772
2018
Q1
$105K Hold
2,752
0.01% 738
2017
Q4
$109K Buy
2,752
+4
+0.1% +$156 0.01% 719
2017
Q3
$103K Buy
2,748
+1,616
+143% +$60.1K 0.01% 688
2017
Q2
$41K Hold
1,132
﹤0.01% 1007
2017
Q1
$40K Hold
1,132
﹤0.01% 972
2016
Q4
$37K Hold
1,132
﹤0.01% 946
2016
Q3
$36K Hold
1,132
﹤0.01% 927
2016
Q2
$34K Buy
1,132
+4
+0.4% +$121 ﹤0.01% 936
2016
Q1
$33K Buy
+1,128
New +$32.1K 0.01% 931

Other funds holding ILCB